Michael Haller, MD

Michael Haller, MD, tell providers they shouldn't be surprised if more children with T1D use inhaled insulin.

Michael Haller, MD, discusses inhaled insulin’s safety, off-label use, and future role in easing type 1 diabetes management for children.

Manufacturer MannKind has submitted a supplemental Biologics Application to the FDA for its inhaled insulin Afrezza.